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Abstract
Background: Listeriosis is a rare disease caused by the bacterium Listeria monocytogenes and mainly affects at risk
people. Listeriosis can lead to sepsis, central nervous system (CNS) infections and death. The objectives of this study
were to describe and quantify comorbidities and neurological sequelae underlying non-perinatal listeriosis cases
and to describe the factors associated with death and CNS infections in non-perinatal listeriosis.
Methods: We retrospectively collected clinical data through computerized, paper or microfilmed medical records in
two Belgian university hospitals. Logistic regression models and likelihood ratio tests allowed identifying factors
associated with death and CNS infections.
Results: Sixty-four cases of non-perinatal listeriosis were included in the clinical case series and 84 % were affected
by at least one comorbid condition. The main comorbidities were cancer, renal and severe cardio-vascular diseases.
Twenty-nine patients (45 %) suffered from a CNS infection and 14 patients (22 %) died during hospitalization,
among whom six (43 %) had a CNS involvement. Among surviving patients, eleven suffered from neurological
sequelae (22 %) at hospital discharge; all had CNS infection. Five of these patients (45 %) still suffered of their
neurological sequelae after a median follow-up of one year (range: 0.08–19). The factor associated with death
during the hospitalization was the presence of a severe cardiovascular disease (OR = 4.72, p = 0.015). Two factors
inversely related with CNS infections were antibiotic monotherapy (OR = 0.28, p = 0.04) and the presence of renal
disease (OR = 0.18, p = 0.02).
Conclusions: In a public health context these results could be a starting point for future burden of listeriosis
studies taking into account comorbidity.
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Background
Listeriosis is caused by Listeria monocytogenes, a gram-
positive bacterium that was first described by Murray et
al. in rabbits and guinea pigs in 1926 [1]. The bacterium
is typically widespread in nature but the main sources of
infection are mainly dairy and ready-to-eat foods [2]. L.
monocytogenes is a high concern for the food industry
because it has the capacity to survive and grow in harsh
conditions such as wide pH ranges, high salt concentra-
tions and at refrigeration temperatures [3].
Listeriosis is a rare disease showing a high case-fatality
ratio. It was estimated that in 2010, listeriosis caused
23,150 illnesses (95 % Credible Interval [CrI]: 6,061-
91,247) and 5,463 deaths (95 % CrI: 1,401-21,497) world-
wide, resulting in 172,823 Disability-Adjusted Life Years
(DALYs) (95 % CrI: 42,079-679,465) [4].
Listeriosis mainly affects at risk groups such as preg-
nant women, the elderly, and patients affected by
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comorbidities such as cancer or transplantation [5]. Co-
morbidity can be defined as the presence of any clinical
condition which qualifies for formal classification as a
disease additional to listeriosis. Three types of comorbidi-
ties can be distinguished: 1) unrelated (diseases/conditions
happening by chance on the same patient); 2) indirectly
related (diseases/conditions with common risk factors
while pathophysiology is unrelated); and 3) directly related
(when pathophysiology shows that one condition can be
regarded as natural consequence or parallel manifestation
of the other condition) [6].
Listeriosis typically affects patients with underlying
diseases and can cause severe symptoms such as sepsis
or central nervous system (CNS) infections, possibly
leading to lifelong consequences or death [5, 7]. It is
therefore important to identify high risk populations and
identify risk factors linked with CNS infections and
death caused by listeriosis.
The aims of our study were 1) to identify and quantify
the comorbidities underlying listeriosis cases, 2) to de-
scribe the factors associated to death and CNS infections
and 3) and to describe and quantify the neurological se-
quelae associated to non-perinatal listeriosis.
Methods
Data collection
We collected information about listeriosis cases in two
Belgian university hospitals: ‘Le centre hospitalier univer-
sitaire’ (CHU) in Liège in the period 2003-2013 and ‘Les
cliniques universitaires saint Luc’ (UCL) in Brussels in the
period 1978-2014 (April). We collected retrospective data
through computerized, paper or microfilmed medical re-
cords. We extracted general information (date of hospital
and discharge admission), information on the patients
characteristics (age, gender, weight, height), information
on medical and surgical antecedents, characteristics of the
patient at admission, blood and cerebrospinal fluid culture
characteristics at admission, treatment received against lis-
teriosis, outcome of listeriosis and information about
follow-up.
The listeriosis cases were detected by laboratories in-
cluded in each hospital and listeriosis was defined when
Listeria monocytogenes was isolated from a sterile site
(blood, cerebrospinal fluid or aortic wall).
All collected data are available in Additional file 1.
Statistical analyses
We evaluated the association between death during
hospitalization and CNS infections, and various potential
risk factors based on literature review, i.e., age at hos-
pital admission, presence of a severe cardiovascular dis-
ease, antibiotic monotherapy, gender, blood pressure,
diabetes mellitus, immunosuppressive therapy, cancer,
alcoholism, renal disease, HIV infection, hepatic disease,
auto-immune disease, immunocompromised status,
neutrophil and lymphocyte count in blood, C-Reactive
Protein (CRP), creatinine, and blood platelets, using uni-
variable logistic regression analyses. All covariates with a
p-value <0.10 were subsequently included in a multivari-
able logistic regression model. The two final models
were chosen based on the Likelihood Ratio Test using a
backward inclusion methodology, testing for the signifi-
cance of elimination of the variable at each stage. We
only retained significant variables in the final models.
For death we started with a full model including anti-
biotic monotherapy, age at admission, hepatic disease,
severe cardiovascular disease, renal disease and trans-
plantation. For CNS infection we started with a full
model including antibiotic monotherapy, immunosup-
pressive therapy and renal disease.
We performed a t-test for equal variances to compare
mean age in antibiotic bi-therapy and antibiotic mono-
therapy groups.
We applied a Mann-Whitney test to compare time
until antibiotic therapy between CNS infection cases and
non CNS infection cases.
We performed the analyses with SPSS 22.0 [8].
Results
We identified 16 non-perinatal listeriosis cases in CHU
and 105 listeriosis cases in UCL. Fifty-seven cases were
excluded from the analysis (33 were not isolated from a
sterile site, 16 medical records were unavailable because
too old, 2 were duplicates, 6 were perinatal cases)
(Fig. 1).
Among the remaining 64 cases, 34 patients were male
(53 %) and the median age was 62 years (Interquartile
interval 53-72) (Fig. 2) (Additional file 1).
All patients, except one, were hospitalized. The me-
dian duration of hospitalization was 22 days (range: 2–
187) (Fig. 3). The exact source of contamination was
never identified, only one patient reported having eaten
camembert but the contamination of the cheese was not
analyzed. Thirteen patients (20 %) were previously hos-
pitalized within the four weeks of hospital admission,
which could suggest a nosocomial infection.
Clinical data
We found that among the 64 people affected by acquired
listeriosis, most frequent comorbidities were ongoing
immunosuppressive treatment (53 %), cancer (34 %), se-
vere cardiovascular disease (30 %) and renal disease
(27 %). 84 % of the patients were affected by at least one
comorbidity (Table 1). One patient was 3 months preg-
nant at admission.
The immunosuppressive treatments were anti-rejection
treatment (n = 13, 32 %), chemotherapy (n = 11, 27 %),
radiotherapy (n = 1, 2 %), corticosteroids (n = 13, 32 %),
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infliximab (n = 2, 5 %). The encountered cancers were
colon (n = 3, 14 %), liver (n = 3, 14 %), breast (n = 3, 14 %),
lung (n = 2, 10 %), leukemia (n = 5, 24 %), myeloma (n = 1,
5 %), lymphoma (n = 3, 14 %) and melanoma (n = 1, 5 %).
The severe cardiovascular diseases (n = 19) were heart
transplantation, heart transplantation followed by a triple
bypass of the transplanted heart followed by high blood
pressure, heart transplantation followed by multiple myo-
cardial infractions and high blood pressure, double heart
transplanted, heart transplantation, angina pectoris and
high blood pressure treated with cardiac bypass, angina
pectoris, ischemic heart disease followed by a heart trans-
plantation and followed by an aortic bypass, myocardial
infarction caused by a ischemic heart disease, myocardial
infarction followed by cardiac decompensation, obstruct-
ive hypertrophic heart disease and essential hypertension
treated by pacemaker, obstructive hypertrophic cardiomy-
opathy, cardiac decompensation, cardiac decompensation
treated by pacemaker, cardiac decompensation treated by
bypass but remaining high blood pressure, aortic
Fig. 1 Selection of cases
Fig. 2 Age distribution of patients (n = 64)
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insufficiency, aortic dissection and high blood pressure,
aortic insufficiency, aortic insufficiency.
The renal diseases were kidney transplantation (n = 6,
35 %), chronic renal disease (n = 7, 41 %), polycystic kid-
ney (n = 1, 6 %), end stage renal (dialysis) disease (n = 2,
12 %), Raynaud disease with cystic kidney (n = 1, 6 %).
The hepatic diseases were congestive hepatopathy (n = 2,
20 %), chronic hepatitis (n = 1, 10 %), hepatitis C (n = 4,
40 %), liver transplantation (n = 1, 10 %), liver cancer
(n = 2, 20 %).
Sixty-four percent of the patients were immunocom-
promised by treatment, cancer or HIV.
Nine patients (14 %) did not suffer from any comor-
bidity. Among these patients the median age was 41.5
(range: 1.3-75.1), 7 patients (78 %) had CNS infection, 6
(67 %) had neurological sequelae at hospital discharge.
One died 19 years after hospital discharge.
Among all cases, the most frequent symptoms at ad-
mission were fever (>38 °C) (77 %), diarrhea (23 %) and
vomiting (13 %). For 20 patients, the median duration
between appearance of symptoms and admission at hos-
pital was 3 days (range: 1–25). Two patients were in-
fected during their hospitalization after 26 and 11 days
respectively (Fig. 3). The first patient was a man hospi-
talized for a heart transplantation and the second was a
woman hospitalized for a breast implant removal.
L. monocytogenes caused a central nervous system in-
fection in 29 patients (45 %). Twenty-seven neurological
cases were confirmed by positive CSF culture and two
by neuroimaging. The mean CSF protein level was 252.6
(sd 227.8) mg/L, the median CSF lymphocytes percent-
age was 40 (range: 2-88) and the median CSF monocytes
percentage was 6 (range: 5.5-6).
Among the neurological cases, the classical triad for
meningitis of neck stiffness, fever and altered mental sta-
tus were present among eight (28 %) of cases. In
addition, 14 (48 %) had headaches, five (17 %) seizures,
six (21 %) were aphasic, six (21 %) showed hemiparesis,
seven (24 %) had cranial nerve palsies, four (14 %) had
nystagmus, five (17 %) suffered from dysarthria and
seven (24 %) had limb and gait ataxia.
The initial reported listeriosis manifestations were:
sepsis for 37 (58 %) patients, endocarditis for one (2 %),
Fig. 3 Patients follow-up after positive listeria culture. * Peritonitis – endocarditis - infrarenal abdominal aortic aneurysm. ** 1) bilateral hearing
loss, 2) discrete dysarthria and mild instability in Romberg (test used to investigate the ataxia. A positive Romberg test suggests that the ataxia is
sensory in nature) and in walking on a straight line, 3) slight diplopia (a trochlear nerve palsy), 4) memory loss and forgetfulness (damage of the
mammillary body and fornix), 5) dystonia (difficulty in opening jaw), 6) persistence of an impaired general condition with small steps walk and
brachypsychie, 7) discrete right dysdiadochokinesia, hypoesthesia in the territory V2, V3 to and an ataxic walk with deviation to the right side, 8)
right hemibody motor deficit with Babinski sign, 9) dysarthria, 10) deep sensitivity deficit of the left arm and left leg and 11) mild paresis of the
right upper and lower limb
Table 1 Comorbidities and factors associated with listeriosis
cases (n = 64)
Comorbidity N %
Immunosuppressive therapy 34 53.1
Cancer 22 34.4
Severe cardiovascular disease 19 29.7
Renal disease 17 26.6
Transplantationa 12 18.8
Hepatic disease 11 17.2
No recognized comorbidities 10 15.6
Diabetes mellitus 8 12.5
HIV 6 9.4
Auto-immune disease 5 7.8
Alcoholism 3 4.7
Pregnancy 1 1.6
a Kidney (6), heart (5), Liver (1)
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peritonitis for one (2 %), infrarenal abdominal aortic
aneurysm for one (2 %), meningitis for 14 (22 %),
meningo-encephalitis for ten (19 %) and rhombo-
encephalitis for one (2 %). One patient suffered from
both brain abscess and rhombo-encephalitis (2 %), one
patient suffered from both brain abscess and meningo-
encephalitis (2 %), one patient suffered from both brain
abscess and encephalitis (2 %) and one patient suffered
from both brain abscess and meningitis (2 %).
Five patients (8 %) suffered from both meningitis and
sepsis, four patients of meningo-encephalitis and sepsis
(6 %), one of encephalitis and sepsis (2 %). For one pa-
tient who suffered of sepsis, L. monocytogenes was also
isolated from his hip prosthesis joint (Fig. 3).
In total 56 patients (92 %) received a parenteral anti-
biotic therapy during hospitalization. Among the 56 pa-
tients, 59 % received a bi-therapy for against listeriosis,
mostly ampicillin and with gentamycin. We did not find
any significant association between age at admission and
the administration of parenteral antibiotic bi-therapy
(p = 0.738). Four neurological cases (14 %) received a
neurosurgical therapy: three external ventricular deriva-
tions of the cerebral fluid and one ventriculostomy. No
patient who developed brain abscesses was operated.
If we assume that antibiotic therapy was implemented
at admission, we did not find significant difference of
time until antibiotic therapy between CNS infection
cases (median 3.5 days, min-max 1-8 days) and non
CNS infection cases (median 3 days, min-max 0-25) (U
Mann-Whitney 53, p = 0.943).
The patient with endocarditis was initially treated
against Candida (fluconazole). Then after he underwent
an explanation of the left aorto-femoral prosthesis and
of the left crossed femoral prosthesis and an implemen-
tation of a homograft left axillary-femoral. The patient
died during hospitalization.
The patient with a L. monocytogenes aneurysm was
successfully operated for a replacement of the abdominal
aorta (cadaveric allograft) during the hospitalization.
The patient for whom L. monocytogenes was isolated
from the hip prosthesis joint was successfully treated
with parenteral gentamycin associated with a surgical
scrub of the hip prosthesis.
During hospitalization 14 patients (22 %) died, among
whom 6 (38 %) had a CNS infection. Listeriosis was
linked to all death at hospital.
Factors associated with CNS infections and death
In the univariate analysis, the factors associated with
neurological listeriosis were antibiotic monotherapy (OR
= 0.31, 95 % CI 0.10-0.93, p = 0.036) and the presence of
a renal disease (OR = 0.27, 95 % CI 0.08-0.95, p = 0.042)
(Table 2). Both variables were retained by the multivari-
able model (presence of a renal disease (OR = 0.18, 95 %
CI 0.04-0.79, p = 0.020), antibiotic monotherapy (OR =
0.28, 95 % CI 0.09-0.92, p = 0.04).
In the univariate analysis, the factors associated with
death during the hospitalization were the presence of a
severe cardiovascular disease (OR = 4.73, 95 % CI 1.35-
16.54, p = 0.015), the presence of a hepatic disease (OR
= 4.07, 95 % CI 1.02-16.30, p = 0.047) and the presence
of a renal disease (OR = 4.0, 95 % CI 1.14-14.05, p =
0.031) (Table 3). At a multivariable level and based on
the likelihood ratio test only the presence of a severe
cardio-vascular disease (OR = 4.73, 95 % CI 1.35-16.54,
p = 0.015) was significant.
Neurological sequelae
Among the surviving patients, eleven (22 %) suffered
from at least one sequela at discharge. The median age
of patients affected by neurological sequelae was 51.1
(range 83.1) years. Among these patients, six (54 %) did
not suffer of any recognized comorbidity but all suffered
of CNS infection. One of the two children included in
the study suffered of neurological sequelae.
The neurological sequelae were: bilateral hearing loss,
discrete dysarthria and mild instability in Romberg (test
used to investigate the ataxia. A positive Romberg test
suggests that the ataxia is sensory in nature) and in
walking on a straight line, slight diplopia (a trochlear
nerve palsy), memory loss and forgetfulness (damage of
the mammillary body and fornix), dystonia (difficulty in
opening jaw), persistence of an impaired general condi-
tion with small steps walk and brachypsychie, discrete
right dysdiadochokinesia, hypoesthesia in the territory
V2, V3 to and an ataxic walk with deviation to the right
side, right hemibody motor deficit with Babinski sign,
dysarthria, deep sensory deficit of the left arm and left
leg and mild paresis of the right upper and lower limb.
Among these eleven patients, two were lost to follow-
up, two died (of a ischemic heart disease and of an un-
known cause) after 3 and 19 years of follow-up and five
still suffered from their neurological sequelae at the last
contact with neurologist (median follow-up: 1 [range:
0.08–19] years (Fig. 3).
Discussion
Among the 64 patients, 84 % suffered from an under-
lying disease. The main comorbidities affecting non-
perinatal listeriosis cases were cancer, renal and severe
cardio-vascular diseases and undergoing immunosup-
pressive therapy. In total, 19 % of the patients included
in the clinical case series were transplanted and one pa-
tient was infected only six days after the cardiac trans-
plantation. In all cases, the source of infection was
unknown. However 20 % of the patients were previously
hospitalized for 4 weeks before admission which could
suggest that the infection was nosocomial. The
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incubation time of L. monocytogenes is very variable
which makes the identification of the source of infection
difficult [9].
Despite most non-perinatal listeriosis cases are people
with comorbid conditions, the study also indicated that
neurological listeriosis can affect people without
(known) underlying diseases and very young immuno-
competent children. Other recent case reports also re-
vealed that listeriosis can affect very young children and
that an appropriate treatment at the onset, based on
intravenous ampicillin in the first line therapy, can avoid
the spread of the infection in the patient [10–13].
To our knowledge this is the first study identifying fac-
tors associated with death and CNS infection. We
identified that people who received a parenteral anti-
biotic monotherapy suffered a CNS infection less fre-
quently than people who received a combination therapy
(ampicillin and an aminoglycoside). An explanation
could be that patients with neurological listeriosis have
more severe initial clinical symptoms and therefore re-
ceived more often broad-spectrum antibiotic therapy at
admission. Although combination therapy is often pro-
moted in patients older than 50 years, we did not find
any significant association between age at admission and
the administration of parenteral antibiotic monotherapy
[14]. Time until antibiotic therapy is started could also
be a significant factor of CNS infection. We collected in-
formation on time of appearance of symptoms for 20
Table 2 Comorbidities and factors associated with neurological listeriosis - Univariate logistic analysis
Neurological listeriosis (n = 29) Not Neurological listeriosis (n = 35)
N % N % OR 95 % CI
Monotherapy (n = 57) 11 42.3 23 71.9 0.31 0.10-0.93**
Male 14 48.3 20 57.1 0.70 0.26-1.88
Saint Luc hospital 23 79.3 29 82.9 0.79 0.27-2.79
Diabetes mellitus 2 6.9 6 17.1 0.36 0.07-1.93
Immunosuppressive therapy 12 41.4 22 62.9 0.42 0.15-1.14
Cancer 11 37.9 11 31.4 1.33 0.47-3.76
Alcoholism 1 3.4 2 5.7 0.59 0.05-6.85
Renal disease 4 13.8 13 37.1 0.27 0.08-0.95**
HIV infection 2 6.9 4 11.4 0.57 0.10-3.38
Transplantation 3 10.3 9 25.7 0.33 0.08-1.37
Severe cardiovascular disease 6 20.7 13 37.1 0.44 0.14-1.37
Hepatic disease 3 10.3 8 22.9 0.40 0.09-1.63
Auto-immune disease 1 3.4 4 11.4 0.28 0.03-2.63
Immunocompromised status 16 55.2 25 71.4 0.49 0.18-1.38
Mean SD Mean SD OR 95 % CI
Age in years at admission 57.6 19.5 60.6 19.1 0.99 0.97-1.02
BMI (n = 33) 23.6 5.6 24.8 5.3 0.96 0.83-1.10
Systole at admission (mmHg) (n = 55) 129.2 32.9 123.3 30.2 1.01 0.99-1.03
Diastole at admission (mmHg) 75.0 12.1 70.8 19.1 1.02 0.98-1.05
% neutrophil in blood at admission (n = 41) 74.1 25.3 74.0 19.1 1.00 0.97-1.03
% lymphocytes in blood at admission (n = 37) 15.5 17.6 14.0 9.3 1.01 0.96-1.06
CRP mg/dl at admission (n = 47) 31.9 33.5 34.2 18.3 0.10 0.99-1.01
Creatinine in blood at admission mg/L (n = 60) 2.8 3.0 4.6 9.9 0.96 0.86-1.06
Blood platelets at admission/L (103) (n = 56) 209.8 95.4 254.8 372.0 1.00 0.99-1.00
Median Range Median Range OR 95 % CI
% neutrophil in CSF (n = 20) 71.5 35.0-94.0 79.0 8.5-94.6 1.00 0.96-1.04
% lymphocytes in CSF (n = 8) 40.0 2.0-88.0 / / / /
Glucose in CSF (mg/dL) (n = 10) 31.0 0.4-74.0 / / / /
Protein in CSF (mg/L) (n = 14) 164.5 27.0-732.0 / / / /
Admission year 1998 1983-2013 2006 1978-2014 0.95 0.90-1.02
**p-value < 0.05
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patients. If we assume that antibiotic therapy was imple-
mented at admission, we did not find significant differ-
ence of time until antibiotic therapy between CNS
infection cases and non CNS infection cases.
We also identified that patients with a renal disease
suffered less frequently (OR = 0.18, p = 0.020) from a
CNS infection. One explanation could be that people
suffering from a chronic renal disease (n = 7) receive a
prophylactic antibiotic therapy that may protect against
CNS infection. We also found that severe cardiovascular
(OR = 4.72, p = 0.015) disease was the main factor associ-
ated with death caused by listeriosis. However, given the
small sample size of our study, these estimates should be
interpreted with caution and in the context of any other
available information [15].
Moreover an acute severe illness (e.g. cardiovascular dis-
eases) was a strong risk factor for mortality at the hospital.
In a public health context our findings could improve
listeriosis burden estimations because we present rare
data on type and duration of sequelae caused by CNS in-
fections associated with listeriosis, both crucial parame-
ters in the calculation of the number of years lived with
disability, one of the two components included in the
DALY calculation [16, 17]. We also think that these
results could be a starting point for future burden of
listeriosis studies aiming to take comorbidities into ac-
count. Ignoring comorbidities, as is the case in many
burden of disease studies, could overestimate the overall
disease burden [6], especially in the context of an ageing
population. Correcting for comorbidities could be relevant
Table 3 Comorbidities and factors associated with death at hospital - Univariate logistic analysis
Death (n = 14) Alive (n = 50)
N % N % OR 95 % CI
CNS infection 6 42.3 23 46.0 0.88 0.27-2.91
Monotherapy (n = 57) 7 77.8 27 56.3 2.72 0.51-14.49
Male 9 64.3 25 50.0 1.80 0.53-6.13
Saint Luc hospital 12 86.0 40 80.0 1.50 0.29-7.81
Diabetes mellitus 2 14.3 6 12.0 1.22 0.22-6.85
Immunosuppressive therapy 8 57.1 26 52.0 1.23 0.37-1.07
Cancer 7 50.0 15 30.0 2.33 0.70-7.82
Alcoholism 0 0.0 3 6.0 / /
Renal disease 7 50.0 10 20.0 4.00 1.14-14.48**
HIV infection 1 7.1 5 10.0 0.69 0.07-6.46
Transplantation 5 35.7 7 14.0 3.41 0.88-13.22
Severe cardiovascular disease 8 57.1 11 22.0 4.73 1.35-16.54**
Hepatic disease 5 35.7 6 12.0 4.07 1.02-16.30**
Auto-immune disease 0 0.0 5 10.0 / /
Immunocompromised status 11 78.6 30 60.0 2.44 0.61-9.88
Mean SD Mean SD OR 95 % CI
Age in years at admission 67.9 9.9 56.8 20.5 1.04 0.98-1.09
BMI (n = 33) 25.4 3.0 24.0 5.8 1.05 0.90-1.23
Systole at admission (mmHg) (n = 55) 116.7 20.6 127.5 32.8 0.99 0.97-1.01
Diastole at admission (mmHg) 68.7 10.5 73.3 17.5 0.98 0.94-1.03
% neutrophil in blood at admission (n = 41) 69.7 30.8 75.1 18.9 0.99 0.96-1.02
% lymphocytes in blood at admission (n = 37) 11.7 9.5 15.2 13.7 0.97 0.89-1.06
CRP mg/dl at admission (n = 47) 55.1 110.5 28.1 32.3 1.01 0.96-1.02
Creatinine in blood at admission mg/L (n = 60) 7.1 15.5 3.0 3.6 1.06 0.97-1.16
Blood platelets at admission/L (103) (n = 56) 170.7 86.3 248.9 314.5 0.98 0.99-1.01
% neutrophil in CSF (n = 20) 83.8 11.5 67.4 23.8 1.06 0.94-1.19
Median Range Median Range OR 95 % CI
Admission year 2004 1984-2013 2003 1978-2014 1.01 0.95-1.07
**p-value < 0.05
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to support policy intervention strategies. Strategies for the
estimation of the prevalence and severity of multimorbid
conditions do exist [18]. However, these strategies typically
assume independence between the occurrence of different
diseases and symptoms. Our estimates show that this is
not true for listeriosis and its comorbidities.
The main limitation of our study may be that it is not
necessarily representative of all non-perinatal listeriosis
cases in Belgium, as the data came from two Belgian
university hospitals. Both hospitals were located in
Brussels and the Walloon region, excluding Flanders.
However, ‘Les Cliniques Universitaires saint Luc’, count-
ing 979 beds, is the third biggest hospital in Belgium
and ‘Le Centre Hospitalier Universitaire’, counting 595
beds, is the second biggest hospital in the Walloon re-
gion. The two hospitals are also affiliated with a univer-
sity and probably received most severe listeriosis cases.
Finally, we expect that patients suffering of a CNS infec-
tion will be frequently transferred to a university hospital
because of the need of intensive care making the repre-
sentativeness of our sample reasonable.
Another weakness of our study may be the retro-
spective design and the long observation duration
(>40 years). However, listeriosis is a rare disease mak-
ing the use of a prospective study design difficult. A
retrospective design and long observation duration
allowed us to collect a study population sufficiently
large to perform a parametric statistical analysis..
Moreover, we did not identify a significant effect of
year at hospital admission on death and on CNS in-
fection. The broad categories of comorbidities allow-
ing statistical analysis could also be a limitation for
clinicians and public health professionals to easily
focus on a specific disease or health condition. To
remedy this, we described each case included in dis-
ease groups (e.g. severe cardiovascular diseases) in
detail.
Conclusion
In a public health context our study could improve bur-
den of listeriosis estimations because we proposed rare
data on type and duration of sequelae caused by CNS
infection associated with listeriosis, both crucial param-
eters in the calculation of the number of healthy life
years lost by a disability, one of the two components in-
cluded in the DALY calculation. Our results could also
be an initial contribution to future burden of listeriosis
studies aiming to take into account multi-morbidity in
summary measure of population health. Additional data
on neurological sequelae and comorbidities underlying
listeriosis collected through other retrospective studies
could be added to the data at hand to improve our
estimations.
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